Ultrasound Responsive Mn/Se‐Nanozyme as PANoptosis Initiators for Bladder Cancer Immunotherapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yisheng Yin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Immunotherapy, Nanoparticles, Ultrasonic Waves. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Bladder cancer is a major global health challenge with high recurrence and mortality. Despite advances in surgery and chemotherapy, immune checkpoint inhibitors (ICIs) have limited effectiveness due to poor immune infiltration and inadequate responses. To address these issues, we developed an ultrasound‐responsive Mn/Se‐NE@FCS nanozyme (NE) that activates both STING signaling and PANoptosis, a novel multi‐pathway cell death mechanism involving apoptosis, necroptosis, and pyroptosis. This dual‐action system enhances ROS production, mitochondrial dysfunction, and immunogenic cell death (ICD) in tumors, promoting dendritic cell (DC) maturation, CD8 + T‐cell infiltration, and memory T‐cell expansion. The Mn/Se‐NE@FCS nanozyme showed superior tumor control and synergized with PD‐1 blockade in murine bladder cancer models. Histological and flow cytometry analyses confirmed that the treatment remodels the tumor microenvironment, driving immune activation and T‐cell priming. This strategy offers a promising nanoimmunotherapy approach for bladder cancer, using ultrasound‐triggered activation to induce multi‐pathway tumor cell death and stimulate long‐lasting systemic immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China.
- Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China.
- State Key Laboratory of Material Processing and Die and Mould Technology, School of Materials Science and Engineering, Huazhong University of Science and Technology, Wuhan, P. R. China.
- Institute for Chemical Research, Kyoto University, Uji, Kyoto, Japan.
- Department of Urology, Taikang Tongji Hospital, Taikang Clinical College of Wuhan University, Wuhan, P. R. China.
ORCID-Profile: Yisheng Yin, Lipiao Bao, Jiajian Gu, Guanglin Huang, Xing Lu, Xiaoyong Zeng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yin, Y., Qin, Z., Zhou, H., Wu, Y., He, Y., Li, X., Wang, J., Ren, X., Tian, Y., Yuan, K., Bao, L., Gu, J., Zhan, L., Huang, G., Lu, X., & Zeng, X. (2026). Ultrasound Responsive Mn/Se‐Nanozyme as PANoptosis Initiators for Bladder Cancer Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504808
Vancouver
Yin Y, Qin Z, Zhou H, Wu Y, He Y, Li X, et al. Ultrasound Responsive Mn/Se‐Nanozyme as PANoptosis Initiators for Bladder Cancer Immunotherapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504808
BibTeX
@article{Yin2026,
author = {Yin, Yisheng and Qin, Zhenliang and Zhou, Hui and Wu, Yizhi and He, Yu and Li, Xing and Wang, Jing and Ren, Xiang and Tian, Yiqun and Yuan, Kun and Bao, Lipiao and Gu, Jiajian and Zhan, Lijun and Huang, Guanglin and Lu, Xing and Zeng, Xiaoyong},
title = {Ultrasound Responsive Mn/Se‐Nanozyme as PANoptosis Initiators for Bladder Cancer Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504808}
}
EUVIMED